产品: | TRRAP 抗体 |
货号: | DF13603 |
描述: | Rabbit polyclonal antibody to TRRAP |
应用: | WB |
反应: | Human, Mouse, Rat |
预测: | Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus |
分子量: | 437kDa; 438kD(Calculated). |
蛋白号: | Q9Y4A5 |
RRID: | AB_2846622 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# DF13603, RRID:AB_2846622.
展开/折叠
350/400 kDa PCAF associated factor; PAF 350/400; PAF 400; PAF350/400; PAF400; STAF 40; STAF40; TR AP; Tra 1; Tra1; Tra1 homolog; Transactivation / transformation domain associated protein; Transactivation/transformation domain associated protein; Transformation/transcription domain associated protein; TRAP;
抗原和靶标
- Q9Y4A5 TRRAP_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MAFVATQGATVVDQTTLMKKYLQFVAALTDVNTPDETKLKMMQEVSENFENVTSSPQYSTFLEHIIPRFLTFLQDGEVQFLQEKPAQQLRKLVLEIIHRIPTNEHLRPHTKNVLSVMFRFLETENEENVLICLRIIIELHKQFRPPITQEIHHFLDFVKQIYKELPKVVNRYFENPQVIPENTVPPPEMVGMITTIAVKVNPEREDSETRTHSIIPRGSLSLKVLAELPIIVVLMYQLYKLNIHNVVAEFVPLIMNTIAIQVSAQARQHKLYNKELYADFIAAQIKTLSFLAYIIRIYQELVTKYSQQMVKGMLQLLSNCPAETAHLRKELLIAAKHILTTELRNQFIPCMDKLFDESILIGSGYTARETLRPLAYSTLADLVHHVRQHLPLSDLSLAVQLFAKNIDDESLPSSIQTMSCKLLLNLVDCIRSKSEQESGNGRDVLMRMLEVFVLKFHTIARYQLSAIFKKCKPQSELGAVEAALPGVPTAPAAPGPAPSPAPVPAPPPPPPPPPPATPVTPAPVPPFEKQGEKDKEDKQTFQVTDCRSLVKTLVCGVKTITWGITSCKAPGEAQFIPNKQLQPKETQIYIKLVKYAMQALDIYQVQIAGNGQTYIRVANCQTVRMKEEKEVLEHFAGVFTMMNPLTFKEIFQTTVPYMVERISKNYALQIVANSFLANPTTSALFATILVEYLLDRLPEMGSNVELSNLYLKLFKLVFGSVSLFAAENEQMLKPHLHKIVNSSMELAQTAKEPYNYFLLLRALFRSIGGGSHDLLYQEFLPLLPNLLQGLNMLQSGLHKQHMKDLFVELCLTVPVRLSSLLPYLPMLMDPLVSALNGSQTLVSQGLRTLELCVDNLQPDFLYDHIQPVRAELMQALWRTLRNPADSISHVAYRVLGKFGGSNRKMLKESQKLHYVVTEVQGPSITVEFSDCKASLQLPMEKAIETALDCLKSANTEPYYRRQAWEVIKCFLVAMMSLEDNKHALYQLLAHPNFTEKTIPNVIISHRYKAQDTPARKTFEQALTGAFMSAVIKDLRPSALPFVASLIRHYTMVAVAQQCGPFLLPCYQVGSQPSTAMFHSEENGSKGMDPLVLIDAIAICMAYEEKELCKIGEVALAVIFDVASIILGSKERACQLPLFSYIVERLCACCYEQAWYAKLGGVVSIKFLMERLPLTWVLQNQQTFLKALLFVMMDLTGEVSNGAVAMAKTTLEQLLMRCATPLKDEERAEEIVAAQEKSFHHVTHDLVREVTSPNSTVRKQAMHSLQVLAQVTGKSVTVIMEPHKEVLQDMVPPKKHLLRHQPANAQIGLMEGNTFCTTLQPRLFTMDLNVVEHKVFYTELLNLCEAEDSALTKLPCYKSLPSLVPLRIAALNALAACNYLPQSREKIIAALFKALNSTNSELQEAGEACMRKFLEGATIEVDQIHTHMRPLLMMLGDYRSLTLNVVNRLTSVTRLFPNSFNDKFCDQMMQHLRKWMEVVVITHKGGQRSDGNESISECGRCPLSPFCQFEEMKICSAIINLFHLIPAAPQTLVKPLLEVVMKTERAMLIEAGSPFREPLIKFLTRHPSQTVELFMMEATLNDPQWSRMFMSFLKHKDARPLRDVLAANPNRFITLLLPGGAQTAVRPGSPSTSTMRLDLQFQAIKIISIIVKNDDSWLASQHSLVSQLRRVWVSENFQERHRKENMAATNWKEPKLLAYCLLNYCKRNYGDIELLFQLLRAFTGRFLCNMTFLKEYMEEEIPKNYSIAQKRALFFRFVDFNDPNFGDELKAKVLQHILNPAFLYSFEKGEGEQLLGPPNPEGDNPESITSVFITKVLDPEKQADMLDSLRIYLLQYATLLVEHAPHHIHDNNKNRNSKLRRLMTFAWPCLLSKACVDPACKYSGHLLLAHIIAKFAIHKKIVLQVFHSLLKAHAMEARAIVRQAMAILTPAVPARMEDGHQMLTHWTRKIIVEEGHTVPQLVHILHLIVQHFKVYYPVRHHLVQHMVSAMQRLGFTPSVTIEQRRLAVDLSEVVIKWELQRIKDQQPDSDMDPNSSGEGVNSVSSSIKRGLSVDSAQEVKRFRTATGAISAVFGRSQSLPGADSLLAKPIDKQHTDTVVNFLIRVACQVNDNTNTAGSPGEVLSRRCVNLLKTALRPDMWPKSELKLQWFDKLLMTVEQPNQVNYGNICTGLEVLSFLLTVLQSPAILSSFKPLQRGIAACMTCGNTKVLRAVHSLLSRLMSIFPTEPSTSSVASKYEELECLYAAVGKVIYEGLTNYEKATNANPSQLFGTLMILKSACSNNPSYIDRLISVFMRSLQKMVREHLNPQAASGSTEATSGTSELVMLSLELVKTRLAVMSMEMRKNFIQAILTSLIEKSPDAKILRAVVKIVEEWVKNNSPMAANQTPTLREKSILLVKMMTYIEKRFPEDLELNAQFLDLVNYVYRDETLSGSELTAKLEPAFLSGLRCAQPLIRAKFFEVFDNSMKRRVYERLLYVTCSQNWEAMGNHFWIKQCIELLLAVCEKSTPIGTSCQGAMLPSITNVINLADSHDRAAFAMVTHVKQEPRERENSESKEEDVEIDIELAPGDQTSTPKTKELSEKDIGNQLHMLTNRHDKFLDTLREVKTGALLSAFVQLCHISTTLAEKTWVQLFPRLWKILSDRQQHALAGEISPFLCSGSHQVQRDCQPSALNCFVEAMSQCVPPIPIRPCVLKYLGKTHNLWFRSTLMLEHQAFEKGLSLQIKPKQTTEFYEQESITPPQQEILDSLAELYSLLQEEDMWAGLWQKRCKYSETATAIAYEQHGFFEQAQESYEKAMDKAKKEHERSNASPAIFPEYQLWEDHWIRCSKELNQWEALTEYGQSKGHINPYLVLECAWRVSNWTAMKEALVQVEVSCPKEMAWKVNMYRGYLAICHPEEQQLSFIERLVEMASSLAIREWRRLPHVVSHVHTPLLQAAQQIIELQEAAQINAGLQPTNLGRNNSLHDMKTVVKTWRNRLPIVSDDLSHWSSIFMWRQHHYQGKPTWSGMHSSSIVTAYENSSQHDPSSNNAMLGVHASASAIIQYGKIARKQGLVNVALDILSRIHTIPTVPIVDCFQKIRQQVKCYLQLAGVMGKNECMQGLEVIESTNLKYFTKEMTAEFYALKGMFLAQINKSEEANKAFSAAVQMHDVLVKAWAMWGDYLENIFVKERQLHLGVSAITCYLHACRHQNESKSRKYLAKVLWLLSFDDDKNTLADAVDKYCIGVPPIQWLAWIPQLLTCLVGSEGKLLLNLISQVGRVYPQAVYFPIRTLYLTLKIEQRERYKSDPGPIRATAPMWRCSRIMHMQRELHPTLLSSLEGIVDQMVWFRENWHEEVLRQLQQGLAKCYSVAFEKSGAVSDAKITPHTLNFVKKLVSTFGVGLENVSNVSTMFSSAASESLARRAQATAQDPVFQKLKGQFTTDFDFSVPGSMKLHNLISKLKKWIKILEAKTKQLPKFFLIEEKCRFLSNFSAQTAEVEIPGEFLMPKPTHYYIKIARFMPRVEIVQKHNTAARRLYIRGHNGKIYPYLVMNDACLTESRREERVLQLLRLLNPCLEKRKETTKRHLFFTVPRVVAVSPQMRLVEDNPSSLSLVEIYKQRCAKKGIEHDNPISRYYDRLATVQARGTQASHQVLRDILKEVQSNMVPRSMLKEWALHTFPNATDYWTFRKMFTIQLALIGFAEFVLHLNRLNPEMLQIAQDTGKLNVAYFRFDINDATGDLDANRPVPFRLTPNISEFLTTIGVSGPLTASMIAVARCFAQPNFKVDGILKTVLRDEIIAWHKKTQEDTSSPLSAAGQPENMDSQQLVSLVQKAVTAIMTRLHNLAQFEGGESKVNTLVAAANSLDNLCRMDPAWHPWL
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - Q9Y4A5 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
K84 | Ubiquitination | Uniprot | |
K163 | Ubiquitination | Uniprot | |
K167 | Ubiquitination | Uniprot | |
T209 | Phosphorylation | Uniprot | |
T211 | Phosphorylation | Uniprot | |
S213 | Phosphorylation | Uniprot | |
S318 | Phosphorylation | Uniprot | |
T324 | Phosphorylation | Uniprot | |
K329 | Ubiquitination | Uniprot | |
K353 | Ubiquitination | Uniprot | |
S434 | Phosphorylation | Uniprot | |
K538 | Ubiquitination | Uniprot | |
T544 | Phosphorylation | Uniprot | |
K551 | Ubiquitination | Uniprot | |
K568 | Ubiquitination | Uniprot | |
K579 | Ubiquitination | Uniprot | |
K584 | Ubiquitination | Uniprot | |
S663 | Phosphorylation | Uniprot | |
S818 | Phosphorylation | Uniprot | |
Y862 | Phosphorylation | Uniprot | |
K897 | Ubiquitination | Uniprot | |
Y914 | Phosphorylation | Uniprot | |
T917 | Phosphorylation | Uniprot | |
S923 | Phosphorylation | Uniprot | |
S929 | Phosphorylation | Uniprot | |
S934 | Phosphorylation | Uniprot | |
K941 | Ubiquitination | Uniprot | |
K951 | Ubiquitination | Uniprot | |
K996 | Ubiquitination | Uniprot | |
Y1007 | Phosphorylation | Uniprot | |
K1016 | Ubiquitination | Uniprot | |
S1044 | Phosphorylation | Uniprot | |
K1222 | Ubiquitination | Uniprot | |
K1236 | Ubiquitination | Uniprot | |
S1263 | Phosphorylation | Uniprot | |
T1271 | Phosphorylation | Uniprot | |
K1357 | Ubiquitination | Uniprot | |
K1385 | Ubiquitination | Uniprot | |
Y1437 | Phosphorylation | Uniprot | |
S1458 | Phosphorylation | Uniprot | |
S1552 | Phosphorylation | Uniprot | |
T1622 | Phosphorylation | Uniprot | |
S1628 | Phosphorylation | Uniprot | |
T1633 | Phosphorylation | Uniprot | |
K1691 | Methylation | Uniprot | |
K1769 | Ubiquitination | Uniprot | |
K1814 | Ubiquitination | Uniprot | |
T1999 | Phosphorylation | Uniprot | |
K2022 | Ubiquitination | Uniprot | |
S2034 | Phosphorylation | Uniprot | |
K2047 | Ubiquitination | Uniprot | |
S2051 | Phosphorylation | Uniprot | |
S2054 | Phosphorylation | Uniprot | |
K2059 | Ubiquitination | Uniprot | |
T2063 | Phosphorylation | Uniprot | |
S2069 | Phosphorylation | Uniprot | |
S2075 | Phosphorylation | Uniprot | |
S2077 | Phosphorylation | Uniprot | |
T2132 | Phosphorylation | Uniprot | |
K2141 | Ubiquitination | Uniprot | |
K2145 | Ubiquitination | Uniprot | |
K2207 | Ubiquitination | Uniprot | |
K2235 | Acetylation | Uniprot | |
S2284 | Phosphorylation | Uniprot | |
T2333 | Phosphorylation | Uniprot | |
K2362 | Ubiquitination | Uniprot | |
K2392 | Ubiquitination | Uniprot | |
K2405 | Methylation | Uniprot | |
K2438 | Ubiquitination | Uniprot | |
K2457 | Ubiquitination | Uniprot | |
S2530 | Phosphorylation | Uniprot | |
K2543 | Acetylation | Uniprot | |
K2543 | Ubiquitination | Uniprot | |
K2582 | Ubiquitination | Uniprot | |
K2597 | Ubiquitination | Uniprot | |
T2601 | Phosphorylation | Uniprot | |
K2638 | Ubiquitination | Uniprot | |
K2724 | Ubiquitination | Uniprot | |
K2829 | Ubiquitination | Uniprot | |
K2968 | Ubiquitination | Uniprot | |
K2972 | Ubiquitination | Uniprot | |
K3050 | Ubiquitination | Uniprot | |
K3078 | Acetylation | Uniprot | |
K3078 | Ubiquitination | Uniprot | |
K3111 | Ubiquitination | Uniprot | |
Y3122 | Phosphorylation | Uniprot | |
S3255 | Phosphorylation | Uniprot | |
S3286 | Phosphorylation | Uniprot | |
K3346 | Ubiquitination | Uniprot | |
K3354 | Ubiquitination | Uniprot | |
K3362 | Ubiquitination | Uniprot | |
K3372 | Ubiquitination | Uniprot | |
K3415 | Ubiquitination | Uniprot | |
K3417 | Ubiquitination | Uniprot | |
K3442 | Ubiquitination | Uniprot | |
K3464 | Ubiquitination | Uniprot | |
S3469 | Phosphorylation | Uniprot | |
K3488 | Ubiquitination | Uniprot | |
K3508 | Ubiquitination | Uniprot | |
Y3526 | Phosphorylation | Uniprot | |
K3558 | Ubiquitination | Uniprot | |
K3598 | Ubiquitination | Uniprot | |
K3604 | Ubiquitination | Uniprot | |
R3618 | Methylation | Uniprot | |
K3639 | Ubiquitination | Uniprot | |
Y3709 | Phosphorylation | Uniprot | |
K3765 | Ubiquitination | Uniprot | |
K3834 | Ubiquitination | Uniprot |
研究背景
Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation. Also involved in transcription activation mediated by the adenovirus E1A, a viral oncoprotein that deregulates transcription of key genes. Probably acts by linking transcription factors such as E1A, MYC or E2F1 to HAT complexes such as STAGA thereby allowing transcription activation. Probably not required in the steps following histone acetylation in processes of transcription activation. May be required for the mitotic checkpoint and normal cell cycle progression. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome.
Nucleus.
Interacts with MYC, E2F1 and E2F4 transcription factors. Interacts directly with p53/TP53. Interacts with GCN5L2. Component of various HAT complexes. Component of the PCAF complex, at least composed of TADA2L/ADA2, SUPT3H, TADA3L/ADA3, TAF5L/PAF65-beta, TAF6L/PAF65-alpha, TAF10/TAFII30, TAF12/TAFII20, TAF9/TAFII31 and TRRAP. Component of the TFTC-HAT complex, at least composed of TAF5L, TAF6L, TADA3L, SUPT3H/SPT3, TAF2/TAFII150, TAF4/TAFII135, TAF5/TAFII100, GCN5L2/GCN5, TAF10 and TRRAP. Component of the NuA4 histone acetyltransferase complex which contains the catalytic subunit KAT5/TIP60 and the subunits EP400, TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2, ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP, YEATS4/GAS41, VPS72/YL1 and MEAF6. Component of the STAGA complex, at least composed of SUPT3H, GCN5L2, SUPT7L, TAF5L, TAF6L, TADA3L, TAD1L, TAF10, TAF12, TRRAP and TAF9. The STAGA core complex is associated with a subcomplex required for histone deubiquitination composed of ATXN7L3, ENY2 and USP22. Component of the BAF53 complex, at least composed of BAF53A, RUVBL1, SMARCA4/BRG1, and TRRAP, which preferentially acetylates histone H4 (and H2A) within nucleosomes. Interacts with NPAT. Interaction with TELO2 AND TTI1. Component of a SWR1-like complex.
The PI3K/PI4K domain is required for the recruitment of HAT complexes, and the MYC-dependent transactivation. Although it is strongly related to the PI3/PI4-kinase family, it lacks the typical motifs that constitute the catalytic site of PI3/PI4-kinase proteins, and lacks such activity.
Belongs to the PI3/PI4-kinase family. TRA1 subfamily.
研究领域
· Human Diseases > Infectious diseases: Viral > HTLV-I infection.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.